dronabinol has been researched along with Osteogenic Sarcoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chang, AE; Rosenberg, SA; Seipp, CA; Shiling, DJ | 1 |
| Barofsky, I; Chang, AE; Goldberg, NH; Rosenberg, SA; Seipp, CA; Shiling, DJ; Simon, RM; Stillman, RC | 1 |
2 trial(s) available for dronabinol and Osteogenic Sarcoma
| Article | Year |
|---|---|
In search of an effective antiemetic: a nusring staff participates in marijuana research.
Topics: Adult; Antiemetics; Attitude of Health Personnel; Clinical Trials as Topic; Double-Blind Method; Dronabinol; Humans; Methotrexate; Nausea; Nurses; Osteosarcoma; Random Allocation; Vomiting | 1980 |
Delata-9-tetrahydrocannabinol as an antiemetic in cancer patients receiving high-dose methotrexate. A prospective, randomized evaluation.
Topics: Adolescent; Adult; Antiemetics; Double-Blind Method; Dronabinol; Drug Evaluation; Female; Humans; Male; Methotrexate; Middle Aged; Nausea; Osteosarcoma; Placebos; Prospective Studies; Vomiting | 1979 |